Table 1.
Disease | Configuration | Model Characteristics | Reference |
---|---|---|---|
Abetalipoproteinemia | 2D culture | Decreased ApoB secretion, intracellular lipid accumulation, increased cell death | [70] |
Alagille Syndrome | 3D organoids containing hepatocytes and cholangiocytes | Impaired bile duct formation and regenerative capacity | [71] |
2D culture | Patient-derived, HLC phenotype uncharacterized | [72] | |
Alcohol-induced Liver Injury | 2D culture | Reduced proliferation, oxidative mitochondrial injury, increased steatosis, and hepatocellular carcinoma markers | [66] |
α-1 Antitrypsin Deficiency | 2D culture | AAT retention, enrichment of fibrosis- and cirrhosis-associated pathways | [54] |
Autosomal Recessive Hypercholesterolemia | 2D culture | Reduced LDL uptake | [73] |
Bile Salt Export Pump (BSEP) Deficiency |
2D culture | Impaired biliary excretion, altered localization of BSEP protein | [74,75] |
Biliary Atresia | 2D culture | Decreased biliary marker expression, increased expression of fibrosis markers | [51,76] |
Citrullinemia Type I | 3D organoids | Accumulation of ammonia, decreased ureagenesis | [47] |
2D culture | Decreased ureagenesis | [77] | |
Familial Hypercholesterolemia | 2D culture | Inability to uptake LDL | [60] |
Hemophilia B | 3D organoids | Production of inactive coagulation factor IX (F9) | [78] |
2D culture | Reduced expression and activity of F9 | [58] | |
2D culture | Aberrant splicing of F9 mRNA leading to reduced F9 expression | [79] | |
Hepatitis B | 3D organoids | Higher susceptibility to HBV infection than 2D culture, increased duration of infectious virus production | [49] |
2D coculture of HLCs and liver non-parenchymal cells | Improved efficiency of infection relative to 2D monoculture due to epidermal growth factor (EGF) modulation of endocytosis | [50] | |
Hepatitis C | 2D culture | Permissive to infection with HCV, upregulation of type I and III interferons in response to infection | [68] |
2D culture | Higher susceptibility to and propagation of HCV compared to Huh7 cells | [80] | |
2D culture | Supportive of full HCV life cycle, increased expression of interferon-stimulated genes | [69] | |
Hepatitis E | 2D culture | Permissive host for hepatitis E virus natural isolates | [67] |
Malaria | 2D culture | Permissive host for infection with Plasmodium species; chemical maturation allows for bioactivation of primaquine | [48] |
mtDNA Depletion Syndrome | 2D culture | Decreased mtDNA copy number, disruption of mitochondrial ultrastructure, reduced mitochondrial respiration/intracellular ATP, increased reactive oxygen species levels | [56] |
2D culture and 3D organoids | Decreased mtDNA, reduced mitochondrial respiration, increased reactive oxygen species, increased sensitivity to iron overload | [81] | |
Nonalcoholic Fatty Liver Disease | 2D culture | Patient-specific lipid droplet formation upon administration of oleic acid, decreased lipid metabolism-associated gene expression in higher levels of steatosis | [82] |
2D culture | Decreased electron transport chain activity, altered transcription of mitochondrial respiration pathways, increased pyruvate carboxylase activity, and fumarate accumulation in response to steatosis induction | [83] | |
2D culture | Defects in V-ATPase assembly leading to increased ApoB secretion | [84] | |
3D organoids with hepatocytes, macrophages, mesenchymal stem cells, and endothelial cells | Spontaneous lipid accumulation in absence of fatty acid supplementation | [85] | |
Niemann–Pick Disease Type C (NPC) | 2D culture | Increased lysosomal accumulation of cholesterol, increased trafficking of NPC1 to lysosomes | [86] |
2D culture | Increased lysosomal cholesterol accumulation, increased cell size, upregulated autophagy and impaired autophagic flux | [87] | |
Ornithine Transcarbamylase Deficiency | 2D culture | Decreased urea secretion | [88] |
Pompe Disease | 2D culture | Accumulation of glycogen in lysosomes | [65] |
Primary Sclerosing Cholangitis | 3D organoids containing cholangiocytes | Altered organoid morphology, increased cellular senescence and inflammatory cytokine secretion | [44] |
Propionic Acidemia | 2D culture | Knockout of propionyl CoA carboxylase | [89] |
Transthyretin (TTR) Amyloidosis | 2D culture | Secretion of abnormal TTR, increased expression of transferrin and unfolded protein response signaling pathways | [90,91] |
Wilson Disease | 2D culture | Patient-derived, HLC phenotype uncharacterized | [92] |
2D culture | Increased trafficking of ATP7B to the Golgi complex, increased rate of ATP7B degradation | [93] | |
Zellweger Spectrum Disorder | 2D culture | Defective peroxisome assembly | [94] |